首页 › 基金 › Lion Point Capital, LP › MLYS
Lion Point Capital, LP 对 MLYS 的持仓历史
MINERALYS THERAPEUTICS INC · 医疗保健
Lion Point Capital, LP 在 Q3 2026 的 13F 申报中披露持有 MLYS(MINERALYS THERAPEUTICS INC)10,500 股,市值约 US$264K,约占其申报组合的 1.53%,在其申报持仓中市值排名第 26 位。 Lion Point Capital, LP 最近 11 个申报季度中有 11 个季度披露了 MLYS 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Lion Point Capital, LP 对 MLYS 的持仓演变
Lion Point Capital, LP 于 Q1 2024 首次披露 MLYS 持仓:60,000 股(约 US$775K)。 该持仓在 Q3 2025 达到峰值 39,000 股,市值约 US$1.5M。 在 11 次申报中,Lion Point Capital, LP 1 次增持、2 次减持、7 次保持不变。 最近一期申报(Q3 2026)显示持股 10,500 股、市值约 US$264K。 持仓曾出现大幅变动:Q2 2024 增持约 32% (随后一个季度股价上涨 4%)、Q3 2025 减持约 51% (随后一个季度股价下跌 4%)、Q4 2025 减持约 73% (随后一个季度股价下跌 25%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 60.00K | $774.60K | 新进 |
| Q2 2024 | 79.00K | $924.30K | 增持 |
| Q3 2024 | 79.00K | $956.69K | 持有 |
| Q4 2024 | 79.00K | $972.49K | 持有 |
| Q1 2025 | 79.00K | $1.25M | 持有 |
| Q2 2025 | 79.00K | $1.07M | 持有 |
| Q3 2025 | 39.00K | $1.48M | 减持 |
| Q4 2025 | 10.50K | $381.05K | 减持 |
| Q1 2026 | 10.50K | $284.44K | 持有 |
| Q2 2026 | 10.50K | $283.29K | 持有 |
| Q3 2026 | 10.50K | $263.87K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MLYS 与 13F 数据
MLYS(MINERALYS THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 50 只申报持有 MLYS,申报仓位最大的包括:Catalys Pacific, LLC (US$196.0M), RA CAPITAL MANAGEMENT, L.P. (US$193.3M), Samsara BioCapital, LLC (US$147.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MLYS 的基金
- Catalys Pacific, LLC 7.80M 股 · $196.00M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 7.69M 股 · $193.32M · Q3 2026
- Samsara BioCapital, LLC 5.87M 股 · $147.54M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.96M 股 · $99.46M · Q3 2026
- Laurion Capital Management LP 2.48M 股 · $62.37M · Q3 2026
- ARMISTICE CAPITAL, LLC 1.60M 股 · $40.21M · Q3 2026
- Andera Partners 1.59M 股 · $40.00M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 1.56M 股 · $39.30M · Q3 2026
- ORBIMED ADVISORS LLC 1.45M 股 · $36.55M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 1.32M 股 · $33.22M · Q3 2026
- Ghisallo Capital Management LLC 1.12M 股 · $28.27M · Q3 2026
- MONTANOVA CAPITAL, LLC 1.10M 股 · $27.67M · Q3 2026
更多关于 Lion Point Capital, LP
常见问题
How long has Lion Point Capital, LP held MLYS?
Lion Point Capital, LP has disclosed MLYS holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Lion Point Capital, LP's current position in MLYS?
As of Q3 2026, Lion Point Capital, LP holds 10.50K shares of MLYS (MINERALYS THERAPEUTICS INC), valued at $263.87K, representing 1.53% of its reported portfolio and ranking #26.
Has Lion Point Capital, LP been buying or selling MLYS?
In the latest 13F filing (Q3 2026), Lion Point Capital, LP held unchanged its position in MLYS. The position peaked in Q3 2025 at 39.00K shares.
Which other funds hold MLYS?
Other major institutional holders of MLYS include Catalys Pacific, LLC, RA CAPITAL MANAGEMENT, L.P., Samsara BioCapital, LLC, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.